ES2085852T3 - Derivados de piperazina ansioliticamente activos. - Google Patents

Derivados de piperazina ansioliticamente activos.

Info

Publication number
ES2085852T3
ES2085852T3 ES88201970T ES88201970T ES2085852T3 ES 2085852 T3 ES2085852 T3 ES 2085852T3 ES 88201970 T ES88201970 T ES 88201970T ES 88201970 T ES88201970 T ES 88201970T ES 2085852 T3 ES2085852 T3 ES 2085852T3
Authority
ES
Spain
Prior art keywords
piperazine derivatives
ansiolytically
active piperazine
active
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88201970T
Other languages
English (en)
Inventor
Jan Hartog
Johannes Mos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of ES2085852T3 publication Critical patent/ES2085852T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE HA ENCONTRADO QUE UN GRUPO DE DERIVADOS DE PIPERAZINA QUE SE SABE QUE TIENE PROPIEDADES REDUCTORAS DE LA PRESION DE LA SANGRE POSEE BUENAS PROPIEDADES ANSIOLITICAS. EN LOS MODELOS DE ENSAYO CON ANIMALES BIEN CONOCIDOS, LOS COMPUESTOS SON ACTIVOS CUANDO SE USAN INTRAPERITONEALMENTE EN DOSIS DE 0.3 MG/KG.
ES88201970T 1987-09-11 1988-09-09 Derivados de piperazina ansioliticamente activos. Expired - Lifetime ES2085852T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702167 1987-09-11

Publications (1)

Publication Number Publication Date
ES2085852T3 true ES2085852T3 (es) 1996-06-16

Family

ID=19850597

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88201970T Expired - Lifetime ES2085852T3 (es) 1987-09-11 1988-09-09 Derivados de piperazina ansioliticamente activos.

Country Status (13)

Country Link
US (1) US4889852A (es)
EP (1) EP0307061B1 (es)
JP (1) JP2749593B2 (es)
AT (1) ATE135576T1 (es)
AU (1) AU618279B2 (es)
CA (1) CA1327163C (es)
DE (1) DE3855121T2 (es)
DK (1) DK172628B1 (es)
ES (1) ES2085852T3 (es)
GR (1) GR3019544T3 (es)
IE (1) IE74200B1 (es)
IL (1) IL87712A (es)
ZA (1) ZA886694B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74200B1 (en) * 1987-09-11 1997-07-16 Duphar Int Res Anxiolytically active piperazine derivatives
US5219855A (en) * 1988-01-29 1993-06-15 Mitsubishi Kasei Corporation Anxiolytic drug
US4983612A (en) * 1989-10-05 1991-01-08 American Home Products Corporation Antihypertensive benzopyran derivatives
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5162324A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie Naphyl piperazines useful as 5-HT1A receptor ligands
EP0605033B1 (en) * 1992-12-21 1999-07-21 Duphar International Research B.V Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ209876A (en) * 1983-10-17 1988-03-30 Duphar Int Res Piperazines and pharmaceutical compositions
EP0190472B1 (en) * 1984-12-21 1989-07-12 Duphar International Research B.V New pharmaceutical compositions having anti-psychotic properties
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
IE74200B1 (en) * 1987-09-11 1997-07-16 Duphar Int Res Anxiolytically active piperazine derivatives

Also Published As

Publication number Publication date
DK497288A (da) 1989-03-12
IE882697L (en) 1989-03-11
IL87712A (en) 1992-12-01
IE74200B1 (en) 1997-07-16
EP0307061B1 (en) 1996-03-20
AU618279B2 (en) 1991-12-19
DE3855121D1 (de) 1996-04-25
IL87712A0 (en) 1989-02-28
CA1327163C (en) 1994-02-22
ATE135576T1 (de) 1996-04-15
GR3019544T3 (en) 1996-07-31
JP2749593B2 (ja) 1998-05-13
JPH01100169A (ja) 1989-04-18
US4889852A (en) 1989-12-26
DK172628B1 (da) 1999-08-02
DK497288D0 (da) 1988-09-07
ZA886694B (en) 1989-06-28
EP0307061A2 (en) 1989-03-15
AU2207688A (en) 1989-05-11
DE3855121T2 (de) 1996-08-22
EP0307061A3 (en) 1991-07-17

Similar Documents

Publication Publication Date Title
ES2076147T3 (es) Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion.
OA07809A (fr) Dérivés de la 1-hétéroaryl-4-/(2,5-pyrrolidinedion-1-yl) alkyl/ pipérazine.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
BG43866A3 (en) Method for preparing of derivatives of 2, 2'- imino- bis- ethanol
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
DE58900183D1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
ES2072263T3 (es) Derivados de 4-aminopiridina.
DK0516588T3 (da) Substituerede diaminophthalimider og analoger
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
AR240945A2 (es) Nuevos derivados de sulfonimidas de acidos aminoetil-fosfonicos y sus sales, procedimiento para prparalos y composiciones herbicidas que los contienen.
BG44374A3 (en) Method for preparing of amino guanidine derivatives
BG45552A3 (bg) Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
NO891894D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
GR1000467B (el) Μεθοδος παρασκευης τρικυκλικων παραγωγων 3-οξο-προπανονιτριλιου.
DE68900152D1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
ES2126911T3 (es) Procedimiento para la preparacion de productos intermedios quirales utiles para la sintesis de agentes fungicidas.
OA07768A (fr) Dérivés d'anillines fongicides.
ES2152319T3 (es) Derivado del benceno util contra isquemias.
ES2093286T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
IT8820117A0 (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
IT8322448A0 (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-a mmino-1,3-propandiolo.
DE3855121D1 (de) Anxiolytisch wirksame Piperazinderivate
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 307061

Country of ref document: ES